WRAL: Duke researchers make strides in finding HIV vaccine
A research team led by Duke University scientists on Friday announced that it found clues in immune systems that could help develop an effective HIV vaccine.
Duke Among Sites to Train First Responders On Infectious Disease Safety
Duke Health is one of eight sites nationally selected to participate in a program to help train first responders and other workers in properly handling infectious disease emergencies.
DHVI-IVQAC Biorepository Receives Accreditation from College of American Pathologists
The Accreditation Committee of the College of American Pathologists (CAP) has awarded accreditation to the Duke Human Vaccine Institute-Immunology Virology Quality Assessment Center’s (DHVI-IVQAC) biorepository based on the results of a recent on-site inspection as part of the CAP’s Accreditation Programs.
Duke Human Vaccine Team Awarded Up to $9 million To Study Fungal Fever
The Duke Human Vaccine Institute’s Vaccine and Treatment Evaluation Unit has received an initial award of approximately $5 million from the National Institute of Allergy and Infectious Diseases (NIAID) to support further research on Valley Fever Pneumonia.
DHVI-IVQAC Biorepository Receives Accreditation from College of American Pathologists
The Accreditation Committee of the College of American Pathologists (CAP) has awarded accreditation to the Duke Human Vaccine Institute-Immunology Virology Quality Assessment Center’s (DHVI-IVQAC) biorepository based on the results of a recent on-site inspection as part of the CAP’s Accreditation Programs.